4.8 Article

Photoredox-catalyzed deuteration and tritiation of pharmaceutical compounds

Journal

SCIENCE
Volume 358, Issue 6367, Pages 1182-+

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aap9674

Keywords

-

Funding

  1. National Institutes of Health (NIH) [R01 GM103558-04]
  2. Agency for Science, Technology and Research (A*STAR)
  3. Japan Society for the Promotion of Science
  4. Merck
  5. Abbvie
  6. BMS
  7. Janssen

Ask authors/readers for more resources

Deuterium- and tritium-labeled pharmaceutical compounds are pivotal diagnostic tools in drug discovery research, providing vital information about the biological fate of drugs and drug metabolites. Herein we demonstrate that a photoredox-mediated hydrogen atom transfer protocol can efficiently and selectively install deuterium (D) and tritium (T) at a-amino sp(3) carbon-hydrogen bonds in a single step, using isotopically labeled water (D2O or T2O) as the source of hydrogen isotope. In this context, we also report a convenient synthesis of T2O from T-2, providing access to high-specific-activity T2O. This protocol has been successfully applied to the high incorporation of deuterium and tritium in 18 drug molecules, which meet the requirements for use in ligand-binding assays and absorption, distribution, metabolism, and excretion studies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available